Tango Therapeutics, Inc.

TNGX

$528M

Small Cap

NASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON155 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 4, 2026

Market Overview

Stock performance and key metrics

TNGX News

Catalyst Timeline

4 upcoming, 0 past

No catalysts found.

4 more catalysts beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

Drug Pipeline

TNG260

Phase 2

Non Small Cell Lung Cancer

TNG462

Phase 2

Locally Advanced Solid Tumor

TNG456

Phase 2

Non Small Cell Lung Cancer

RMC-9805

Phase 2

PDAC

TNG908

Phase 2

Locally Advanced Solid Tumor

Drug Name	Phase	Indication	Designations	Patent
TNG260	Phase 2	Non Small Cell Lung Cancer	-	-
TNG462	Phase 2	Locally Advanced Solid Tumor	-	-
TNG456	Phase 2	Non Small Cell Lung Cancer	-	-
RMC-9805	Phase 2	PDAC	-	-
TNG908	Phase 2	Locally Advanced Solid Tumor	-	-

Catalyst Verdict

Market-Implied Move

Regulatory Approvals

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Tango Therapeutics, Inc.

Market Overview

TNGX News

Catalyst Timeline

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals